Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
| ▸ | PPARD | Q03181 | 1/20 | 0.41 |
| ▸ | PPARA | Q07869 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | TYR | P14679 | 1/20 | 0.40 |
| ▸ | CD209 | Q9NNX6 | 2/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | SYNJ2 | O15056 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ABL1 | P00519 | 1/20 | 0.39 |
| ▸ | ALPL | P05186 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | ALPI | P09923 | 1/20 | 0.39 |
| ▸ | ALPG | P10696 | 1/20 | 0.39 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Maltitol SCHEMBL3708375 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 | |
| Maltitol SCHEMBL18744689 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 | |
| Maltitol SCHEMBL8600577 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 | |
| Maltitol SCHEMBL7149629 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 | |
| Maltitol SCHEMBL18744690 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 | |
| Maltitol SCHEMBL13912565 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 | |
| Maltitol SCHEMBL21947405 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 | |
| Maltitol SCHEMBL21947406 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 | |
| Maltitol SCHEMBL22516409 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 | |
| Maltitol SCHEMBL16153886 | 1.00 | L3MBTL1 (0.41) | L3MBTL1PPARGPPARDPPARAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130178616-A1 | USE OF MODIFIED OLIGO-B-(1,3)-GLUCANES FOR TREATING DISEASES OF THE IMMUNE SYSTEM OLIGO-B-(1,3V-GLUCANE-(1,3)-MANNOSE, OLIGO-B-(1,3)-GLUCANE-(1,3)-MANNITOL AND DERIVATIVES THEREOF, METHODS FOR PREPARING THE SAME AND DRUGS CONTAINING THEM | ASE & BIO. (FR) | 2013-07-11 | — | — | US | disclosed |
| US-8367641-B2 | Use of modified oligo-β-(1,3)-glucans for treating diseases of the immune system, oligo-β-(1,3)-glucan-(1,3)-mannose, oligo-β-(1,3)-glucan-(1,3)-mannitol and derivatives thereof, methods for preparing them and medicaments containing them | ASE & BIO (FR) | 2013-02-05 | — | — | US | disclosed |
| US-20100286388-A1 | USE OF MODIFIED OLIGO-B-(1,3)-GLUCANS FOR TREATING DISEASES OF THE IMMUNE SYSTEM, OLIGO-B- (1,3V-GLUCAN-(1,3)- MANNOSE, OLIGO-B-(1,3)-GLUCAN-(1,3)- MANNITOL AND DERIVATIVES THEREOF, METHODS FOR PREPARING THEM AND MEDICAMENTS CONTAINING THEM | ASE & BIO (FR) | 2010-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130178616-A1 | USE OF MODIFIED OLIGO-B-(1,3)-GLUCANES FOR TREATING DISEASES OF THE IMMUNE SYSTEM OLIGO-B-(1,3V-GLUCANE-(1,3)-MANNOSE, OLIGO-B-(1,3)-GLUCANE-(1,3)-MANNITOL AND DERIVATIVES THEREOF, METHODS FOR PREPARING THE SAME AND DRUGS CONTAINING THEM | MANBA, MAN2A1, MAN2B1 | L3MBTL1 154/4885PPARG 3130/4885PPARD 3703/4885 |
| US-20100286388-A1 | USE OF MODIFIED OLIGO-B-(1,3)-GLUCANS FOR TREATING DISEASES OF THE IMMUNE SYSTEM, OLIGO-B- (1,3V-GLUCAN-(1,3)- MANNOSE, OLIGO-B-(1,3)-GLUCAN-(1,3)- MANNITOL AND DERIVATIVES THEREOF, METHODS FOR PREPARING THEM AND MEDICAMENTS CONTAINING THEM | MAN2A1, MANBA, MAN2B1 | L3MBTL1 780/4885PPARG 4710/4885PPARD 4759/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.